Myasthenia Gravis, Generalized clinical trials at UC Irvine
1 research study open to eligible people
open to eligible people ages 18 years and up
Efficacy and safety of amifampridine phosphate in improving the activities of daily living for patients with antibody positive MuSK myasthenia gravis.
Irvine, California and other locations